| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |